Citius Pharmaceuticals, Inc. (CTXR)
0.709
+0.02
(+2.60%)
USD |
NASDAQ |
Feb 20, 16:00
0.6945
-0.01
(-2.05%)
After-Hours: 20:00
Citius Pharmaceuticals Total Assets (Quarterly) : 140.39M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Citius Oncology, Inc. | 109.97M |
| Dynavax Technologies Corp. (DELISTED) | 946.51M |
| Dermata Therapeutics, Inc. | 5.071M |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.92M |
| Shareholders Equity (Quarterly) | 79.96M |
| Debt to Equity Ratio | 0.0229 |
| Current Ratio | 0.9931 |
| Net Debt Paydown Yield | -1.80% |